The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers

NCT01983358 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke

Interventions

DRUG: JPI-289
OTHER: Placebo

Sponsor

Jeil Pharmaceutical Co., Ltd.